<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title> Race and Sex Disparities in Mitral Valve Edge-to-Edge Repair </title>
  <description>In this week’s&amp;amp;nbsp;View,&amp;amp;nbsp;Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men.&amp;amp;nbsp;He reviews the SOGALDI-PEF trial, where patients with low plasma renin levels experienced greater blood pressure reduction with spironolactone/dapagliflozin compared to dapagliflozin alone.&amp;amp;nbsp;Next,&amp;amp;nbsp;he&amp;amp;nbsp;discusses the FAVOR III trial, which found that QFR-guided&amp;amp;nbsp;percutaneous coronary intervention&amp;amp;nbsp;improved five-year outcomes versus angiography guidance, with most benefits occurring in the first two years. Lastly,&amp;amp;nbsp;Dr. Eagle&amp;amp;nbsp;examines two renal disease studies addressing&amp;amp;nbsp;optimal&amp;amp;nbsp;chronic kidney disease&amp;amp;nbsp;(CKD)&amp;amp;nbsp;GFR thresholds and the benefits of&amp;amp;nbsp;finerenone&amp;amp;nbsp;in CKD patients.&amp;amp;nbsp; </description>
  <author_name>Eagle's Eye View: Your Weekly CV Update From ACC.org</author_name>
  <author_url>http://www.acc.org</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41669135/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/203027720</thumbnail_url>
</oembed>
